ET-01 in Subjects With Lateral Canthal Lines, LCL-208
Clinical trial NCT03839693 · COMPLETED
Trial details
- NCT number
- NCT03839693
- Sponsor
- Eirion Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2019-04-18
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.